Status:
COMPLETED
Anaesthesia for Supratentorial Tumor Resection
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Supratentorial Neoplasms
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
This is a double center, multidisciplinary, prospective, randomized, double-blind, with a superiority hypothesis, trial including 100 patients scheduled for resection of a supratentorial brain tumour ...
Detailed Description
On the morning of surgery, patients will be randomly allocated to one of the two following groups : target concentration-delivered propofol-remifentanil versus sufentanil-sevoflurane. The primary judg...
Eligibility Criteria
Inclusion
- Patient scheduled for supratentorial brain tumors remove.
- Age : 18 to 75.
- ASA 1 or 2.
Exclusion
- Disagree of patient to participate
- Intubation required in the postoperative care unit
- Contraindication of one of the anesthetics used in the study
- Pregnancy
- Craniotomy in the frontal area (no depth of anesthesia monitoring)
- Patient's inability to quantified its pain.
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT00389883
Start Date
November 1 2006
End Date
November 1 2011
Last Update
July 10 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire.
Besançon, France, 25030 CEDEX
2
Hopital BEAUJON ASSISTANCE PUBLIQUE
Clichy, France, 92110